Stay updated on Pembrolizumab in mHSPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.

Latest updates to the Pembrolizumab in mHSPC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew revision entry v3.4.2 was added to the history and the government funding notice and Revision: v3.4.1 were removed; these changes are administrative and relate to page display and record-keeping rather than the underlying study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedThe page adds a site-wide notice about potential delays due to a lapse in government funding and updates the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.7%

- Check28 days agoChange DetectedUI improvements include a Show glossary option and color-coded highlights for additions (green) and deletions (red). The page also updates revision/version information and removes the No FEAR Act Data notice.SummaryDifference0.9%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the study's version history.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the page history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. These updates are minor footer/navigation changes and do not affect core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedThe history now includes a new revision entry 'Revision: v3.3.2' and removes the previous 'Revision: v3.3.1' from the list.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.